{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:11:54Z","timestamp":1775736714233,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"DOI":"10.1038\/s41443-026-01264-1","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:30:12Z","timestamp":1775734212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral suspension versus tablet sildenafil for erectile dysfunction: a prospective multicenter comparative study on patient satisfaction"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-3656","authenticated-orcid":false,"given":"Borja","family":"Garc\u00eda-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-2097","authenticated-orcid":false,"given":"Manuel","family":"Alonso-Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Garc\u00eda-Rojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9706-8516","authenticated-orcid":false,"given":"Celeste","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0666-5105","authenticated-orcid":false,"given":"Javier","family":"Romero-Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"1264_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","volume":"200","author":"AL Burnett","year":"2018","unstructured":"Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633\u201341.","journal-title":"J Urol"},{"key":"1264_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eururo.2025.04.010","volume":"88","author":"A Salonia","year":"2025","unstructured":"Salonia A, Capogrosso P, Boeri L, Cocci A, Corona G, Dinkelman-Smit M, et al. European association of urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and Peyronie\u2019s disease. Eur Urol. 2025;88:76\u2013102.","journal-title":"Eur Urol"},{"key":"1264_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","volume":"338","author":"I Goldstein","year":"1998","unstructured":"Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med. 1998;338:1397\u2013404.","journal-title":"N Engl J Med"},{"key":"1264_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4081\/aiua.2016.2.128","volume":"88","author":"V Mirone","year":"2016","unstructured":"Mirone V, Fusco F, Parazzini F, Zucchi A. A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol. 2016;88:128\u201332.","journal-title":"Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol"},{"key":"1264_CR5","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00345-020-03233-9","volume":"39","author":"CR Madeira","year":"2021","unstructured":"Madeira CR, Tonin FS, Fachi MM, Borba HH, Ferreira VL, Leonart LP, et al. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis. World J Urol. 2021;39:953\u201362.","journal-title":"World J Urol"},{"key":"1264_CR6","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.2174\/138161209789206944","volume":"15","author":"TF Al-Shaiji","year":"2009","unstructured":"Al-Shaiji TF, Brock GB. Phosphodiesterase type 5 inhibitors for the management of erectile dysfunction: preference and adherence to treatment. Curr Pharm Des. 2009;15:3486\u201395.","journal-title":"Curr Pharm Des"},{"key":"1264_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/00005392-199909010-00024","volume":"162","author":"JP Jarow","year":"1999","unstructured":"Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol. 1999;162:722\u20135.","journal-title":"J Urol"},{"key":"1264_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1098-3597(05)80049-3","volume":"7","author":"GI Hackett","year":"2005","unstructured":"Hackett GI. Patient preferences in treatment of erectile dysfunction: the continuing importance of patient education. Clin Cornerstone. 2005;7:57\u201365.","journal-title":"Clin Cornerstone"},{"key":"1264_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0090-4295(02)01752-1","volume":"60","author":"H Padma-nathan","year":"2002","unstructured":"Padma-nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60:67\u201390.","journal-title":"Urology"},{"key":"1264_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1743-6109.2006.00233.x","volume":"4","author":"P Str\u00f6berg","year":"2007","unstructured":"Str\u00f6berg P, Hedelin H, Bergstr\u00f6m A. Is sex only for the healthy and wealthy? J Sex Med. 2007;4:176\u201382.","journal-title":"J Sex Med"},{"key":"1264_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.urology.2014.02.016","volume":"83","author":"J Romero Otero","year":"2014","unstructured":"Romero Otero J, Garc\u00eda G\u00f3mez B, Medina Polo J, Jim\u00e9nez Alcaide E, Garc\u00eda Cruz E, Sallent Font A, et al. Evaluation of current errors within the administration of phosphodiesterase-5 inhibitors after more than 10 years of use. Urology. 2014;83:1334\u20138.","journal-title":"Urology"},{"key":"1264_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1743-6109.2007.00688.x","volume":"5","author":"C Ljunggren","year":"2008","unstructured":"Ljunggren C, Hedelin H, Salomonsson K, Str\u00f6berg P. Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance. J Sex Med. 2008;5:469\u201375.","journal-title":"J Sex Med"},{"key":"1264_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jsm.12818","volume":"12","author":"PR Burns","year":"2015","unstructured":"Burns PR, Rosen RC, Dunn M, Baygani SK, Perelman MA. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5\u2009mg once daily. J Sex Med. 2015;12:720\u20137.","journal-title":"J Sex Med"},{"key":"1264_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/PPA.S3937","volume":"3","author":"P Costa","year":"2009","unstructured":"Costa P, Grivel T, Gehchan N. Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives. Patient Prefer Adherence. 2009;3:105\u201311.","journal-title":"Patient Prefer Adherence"},{"key":"1264_CR15","first-page":"759","volume":"13","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA, Moore J, Niecestro R. Pharmacokinetic parameters of a novel sildenafil oral liquid suspension administered to healthy adult men under fasted conditions. Int J Sci Res IJSR. 2024;13:759\u201364.","journal-title":"Int J Sci Res IJSR"},{"key":"1264_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.56434\/j.arch.esp.urol.20237602.15","volume":"76","author":"F Peinado Ibarra","year":"2023","unstructured":"Peinado Ibarra F, Garc\u00eda G\u00f3mez B, Luj\u00e1n Marco S, Segura Pa\u00f1os AM. Study UNICO: perception of urologists and andrologists, in spain, about the use of sildenafil oral suspension in patients with erectile dysfunction. Arch Esp Urol. 2023;76:139\u201344.","journal-title":"Arch Esp Urol"},{"key":"1264_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41443-025-01019-4","volume":"37","author":"L Boeri","year":"2025","unstructured":"Boeri L, Graps G, Zino E, Zago A, Li Puma A, Ciamarra F, et al. Effectiveness and patient satisfaction with the new sildenafil oral suspension formulation compared to sildenafil oro-dispersible film: a real-life study. Int J Impot Res. 2025;37:902\u20137.","journal-title":"Int J Impot Res"},{"key":"1264_CR18","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41443-025-01035-4","volume":"37","author":"L Boeri","year":"2025","unstructured":"Boeri L, Palumbo F, Cai T, Miacola C, Ceruti C, Bitelli M, et al. Bedtime sildenafil oral suspension improves sexual spontaneity and time-concerns compared to on-demand treatment in men with erectile dysfunction: results from a real-life, cross-sectional study. Int J Impot Res. 2025;37:908\u201313.","journal-title":"Int J Impot Res"},{"key":"1264_CR19","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/ijerph20031830","volume":"20","author":"E D\u00edaz-Mohedo","year":"2023","unstructured":"D\u00edaz-Mohedo E, Melda\u00f1a S\u00e1nchez A, Cabello Santamar\u00eda F, Molina Garc\u00eda E, Hern\u00e1ndez Hern\u00e1ndez S, Hita-Contreras F. The spanish version of the international index of erectile function: adaptation and validation. Int J Environ Res Public Health. 2023;20:1830.","journal-title":"Int J Environ Res Public Health"},{"key":"1264_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1743-6109.2006.00400.x","volume":"4","author":"N Zinner","year":"2007","unstructured":"Zinner N. Do food and dose timing affect the efficacy of sildenafil? A randomized placebo-controlled study. J Sex Med. 2007;4:137\u201344.","journal-title":"J Sex Med"},{"key":"1264_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","volume":"53","author":"SE Althof","year":"1999","unstructured":"Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53:793\u20139.","journal-title":"Urology"},{"key":"1264_CR22","doi-asserted-by":"publisher","first-page":"e13073","DOI":"10.1111\/ijcp.13073","volume":"72","author":"JC Cappelleri","year":"2018","unstructured":"Cappelleri JC, Tseng LJ, Stecher VJ, Althof SE. Clinically important difference on the erectile dysfunction inventory of treatment satisfaction questionnaire in patients with erectile dysfunction. Int J Clin Pract. 2018;72:e13073.","journal-title":"Int J Clin Pract"},{"key":"1264_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.23736\/S2724-6051.23.05552-0","volume":"76","author":"C Manfredi","year":"2024","unstructured":"Manfredi C, Franco A, Ditonno F, Mathur R, Franco G, Lombardo R, et al. Treatment preferences of patients with erectile dysfunction: a systematic review of randomized controlled trials. Minerva Urol Nephrol. 2024;76:42\u201351.","journal-title":"Minerva Urol Nephrol"},{"key":"1264_CR24","doi-asserted-by":"publisher","first-page":"I14","DOI":"10.1002\/clc.4960271305","volume":"27","author":"AD Seftel","year":"2004","unstructured":"Seftel AD. Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles. Clin Cardiol. 2004;27:I14\u201319.","journal-title":"Clin Cardiol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01264-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:30:13Z","timestamp":1775734213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01264-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":24,"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1038\/s41443-026-01264-1","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}